Plug and Play Bone Repair: Printing of Bioceramic Implants

Bone takes a long time to grow and repair, so treating serious damage or carrying out reconstructive procedures can be a slow and painstaking process. Writing in issue 6 of Advanced Materials, Jake Barralet of the Faculty of Dentistry, at McGill University, (Montréal, Québec) and Uwe Gbureck, Department for Functional Materials in Medicine and Dentistry, University of Würzburg, (Bavaria) and their team describe a method for "printing" artificial bone from the same chemical components as living bone and including biomolecules that trigger blood vessel growth to bring the bone to life after it is implanted in the body.

The process could be much more effective and less risky than removing sections of bone from elsewhere in the body for grafting on to an injured site.

The McGill - Würzburg team has demonstrated how an artificial bone can be constructed using the minerals brushite and hydroxyapatite instead of conventional "ink" in their printer. By printing one layer on top of another they can build up a highly porous 3D bioceramic material resembling bone at room temperature.

The team also adds natural chemicals to stimulate blood vessel growth - vascular endothelial growth factor (VEGF) or copper sulphate. This allows them to incorporate into their model bone implants the necessary materials for stimulating blood vessel growth and allowing the artificial bone grafts to "grow" into the site being repaired.

Regenerative medicine is a growing field. Researchers are developing the various techniques that will allow them to construct tissues, including bone, muscle, and even whole organs, outside the human body for subsequent implantation. The biochemistry of tissue repair and integration of such engineered tissues does, however, complicate what would otherwise be a straightforward process of simply grafting the newly grown tissue on to the damage site.

Tissue growth, explain the researchers, is guided by a whole range of cellular signaling molecules that ebb and flow over time, switching on and off yet more molecules that trigger growth, and crucially, growth of blood vessels into a tissue.

By incorporating the blood vessel growth factors into their artificial bone implants, Barralet and colleagues hope that their approach will allow acceleration of integration of such implants into a graft site. "This low-temperature direct approach offers several practical advantages and may find application in bone grafting," the researchers say.

The team has so far tested blood vessel growth into the implant materials made with and without VEGF. They found that blood vessels can grow only one or two millimetres into the pores of VEGF-free artificial bone. In contrast, the artificial bone made with added VEGF promotes blood vessels growth throughout its network of pores. Such a demonstration bodes well for the further development of bespoke printable bone grafts.

Citation: Jake Barralet, Direct Printing of Bioceramic Implants with Spatially Localized Angiogenic Factors, Advanced Materials 2007, 19, No. 6, doi: 10.1002/adma.200601370

Source: Wiley

Can stem cells heal damaged hearts? No easy answers, but some signs of hope
Recent studies indicate that infusing hearts with stem cells taken from bone marrow could improve cardiac function after myocardial infarction (tissue damage that results from a heart attack). But in a recent systematic review, Cochrane Researchers concluded that more clinical trials are needed to assess the effectiveness of stem cell therapies for heart patients, as well as studies to establish how these treatments work.
New leukemia signal could point way to better treatment
Cancer researchers at the Stanford University School of Medicine have discovered a promising new chemotherapy target for a deadly form of leukemia. Their discovery hinges on a novel "double agent" role for a molecular signal that regulates cell growth.
Embryonic stem cells might help reduce transplantation rejection
Researchers have shown that immune-defense cells influenced by embryonic stem cell-derived cells can help prevent the rejection of hearts transplanted into mice, all without the use of immunosuppressive drugs.
Antiangiogenic drugs impede chemotherapy-stimulated tumor recovery
Scientists have gained new insight into a mechanism whereby chemotherapy may actually assist the rapid regrowth of tumors after treatment. The research, published by Cell Press in the September issue of the journal Cancer Cell, also helps to explain why a combination of traditional chemotherapy with drugs that block formation of new blood vessels might impede the devastating tumor recovery that often follows cancer therapy.

Researchers devise means to create blood by identifying earliest stem cells
Johns Hopkins researchers have discovered the earliest form of human blood stem cells and deciphered the mechanism by which these embryonic stem cells replicate and grow. They also found a surprising biological marker that pinpoints these stem cells, which serve as the progenitors for red blood cells and lymphocytes.
Protein key to control, growth of blood cells
New research sheds light on the biological events by which stem cells in the bone marrow develop into the broad variety of cells that circulate in the blood. The findings may help improve the success of bone marrow transplants and may lead to better treatments for life-threatening blood diseases.
Duck-billed dinosaurs outgrew predators to survive
With long limbs and a soft body, the duck-billed hadrosaur had few defenses against predators such as tyrannosaurs. But new research on the bones of this plant-eating dinosaur suggests that it had at least one advantage: It grew to adulthood much faster than its predators, giving it superiority in size.
'Stuffy nose' mouse: A promise to help treat 31 million with sinusitis
Mice with inflamed nasal tissue being tested at a Johns Hopkins laboratory may be unable to tell if something smells bad or good, but their sensory deficit is nothing to turn up a nose at.

Plug and Play Bone Repair: Printing of Bioceramic Implants

Related stories:

News discussion: